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The Neurotrophins and Bone Morphogenic Proteins (BMP) have both
been implicated in the maintenance of cellular proliferation and apoptosis in the
developing nervous system. Downstream of both signaling pathways is NRAGE,
a member of the Melanoma Antigen (MAGE) gene family and, under BMP
stimulation, activates p38 leading to caspase 3 cleavage. NRAGE possesses a
highly conserved MAGE Homology Domain (MHD) and a second, less well
conserved MHD (denoted MHD2) as well as a unique 25 tandem WQXPXX
hexapeptide repeat region. Binding partners for the MHD and hexapeptide repeat
regions have been identified but their cellular consequences have not been
defined. Therefore, a structure-function analysis of NRAGE was performed to
identify whether it is the MHD or the repeat region that tranduces the apoptotic

signal. Nine NRAGE deletion mutants were built to isolate the identified regions
and expressed in PI9 cells, a neural development model system. Through
Annexin V staining, it was found that the MHD is essential for apoptotic function
and the hexapeptide repeat region does decrease the degree of cellular death. The
MHD region also induces p38 activation and caspase 3 cleavage, as well as
apoptosis.

Overall, these studies ascribe yet another function to the highly

conserved MHD and give further insight into the mechanisms governing neural
progenitor cell apoptosis.
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Chapter 1

INTRODUCTION

Apoptosis is an Active and Selective Mechanism in Neural Development
The development of the mammalian nervous system begins in the early
stages of embryogenesis and is not complete until the organism reaches
adulthood. The brain and spinal cord are derived from the neural tube, a single
layer of cells generated from the neuroepithelium.

The cerebral cortex is

generated through a series of events through which proliferation and
diversification of a neural stem cell begins with its birth and its terminal function
is defined by its birth date and the environment in which it receives its cues'
(reviewed in

2).

There is a significant overproduction of neurons and, as a result,

the brain is developed through a finely balanced mechanism of cell proliferation
and apoptosis, or programmed cell death

'-'.

Too little proliferation or too much

apoptosis in development can result in mental retardation and dementia later in
life (reviewed in 6 ) . Conversely, too much proliferation or too little apoptosis can
result in neuroblastomas and astrogliomas, central nervous system cancers with

very poor prognosis. Thus, an extremely significant method of both pruning the
developing brain and maintaining tissue homeostasis is apoptosis.
Apoptosis is often the cells' response to genetic instability, working on the
premise that a cell is better dead than damaged (reviewed in 7). However,
apoptosis or programmed cell death, is also a normal developmental mechanism
to control cell number and remodel tissues 9. The molecules involved in apoptosis
are evolutionarily conserved with a substantial expansion of gene families as the
phylogenic tree diversifies 7. Caspases (cystienyl, =artate

specific prote-)

are

major executioners of the apoptotic process and are subdivided into initiator and
executioner molecules, both of which require dimerization and proteolytic
cleavage to initiate downstream effects. Upon internally mediated mitochondria1
permeabilization, cytochrome C is released and forms the apoptosome, an
aggregate of APAF- 1 (apoptosis protease activating factor), ATP, and cytochrome
c (the intrinsic apoptotic pathway, reviewed in 7). Herein the pro- initiator
caspases are cleaved and these molecules can subsequently initiate the cleavage of
executioner caspases (such as 3 and 7) which leads to cell death (figure 1). The
extrinsic pathway works ultimately in a similar mechanism but is initiated through
cell external cues. Upon appropriate ligand binding, the extrinsic pathway can
utilize molecules such as SMACIDiablo (Second Mitochondria1 Activator of
CaspaseIDirect IAP binding protein with low PI) to release the inhibition that an
Inhibitor of Apoptosis (IAP, XIAP being the prototypic molecule) family member
has on caspase cleavage (Reviewed in 7).

Labeling of apoptotic cells by virtue of their fragmented DNA showed that
apoptosis is substantial in the developing mouse cortex, beginning at around E
(embryonic day) 12, peaking at E l 4 and decreasing to nearly negligible levels in
the adult

4.

The majority of apoptotic cells in the developing brain are in the

proliferative zones of the developing cortex such as the primoridal plexiform
layer and the ventricular zone 4.
Up to 70% of cells are dying in the proliferative zones at E l 4 and this
steadily decreased until about 1% of cells are actively apoptosing in the adult

'.

Furthermore, a large proportion of apoptotic cells are actively synthesizing DNA
within an hour prior to death, as shown by BrdU staining

? This suggests that

cells are active in the cell cycle as they are apoptosing, indicating that cell cycle
activity is a significant event in initiating apoptosis. Although the dogma has
been that post-mitotic neurons can not re-enter the cell cycle, current theories
suggest that post-mitotic neurons can re-enter the cell cycle but this triggers
apoptosis

lo.

Several cell cycle molecules such as cyclin D-CKD and RbtE2F are

upregulated in cortical neurons and cell culture lines exposed to apoptosis
inducing factors such as UV-irradiation

11

. Furthermore, Gl/S checkpoint

molecules, such as CDK416, Rb, p107 and p130, have all been shown to be
critical for post-mitotic neuron survival, thus expression in post-mitotic neurons is
often observed in cells undergoing apoptosis signaling events (reviewed in

12

).

Overall, this demonstrates that post-mitotic neurons have a fail-safe mechanism;
for when the cell cycle exit checkpoints are breached, apoptosis cascades are soon

triggered, preventing the cell from re-entering the cell cycle and possibly damage
the cell and organ as a whole.

Identification of NRAGE and Regulation of NRAGE Expression and Activity
Using the p751cD (Intracellular Domain) as bait, a single clone from an E l 3
(embryonic day 13) mouse library was isolated and named NRAGE for
Neurotropin Receptor-Interacting MAGE Homolog 13. In parallel, two similar
proteins, MAGE-Dl

l4

and Dlxin-1

l5

were cloned from human and mouse yeast-

two hybrid screens respectively. These were subsequently found to be orthologs
with 87% identity to the human MAGE-Dl and with 97% identity in the cterminal 3 15 amino acids, including the hexapeptide repeat region

13.

NRAGE is

encoded on the X-chromosome and contains a MAGE homology domain (MHD)
as well as a 25 tandem WQXPXX hexapeptide repeat region (unique to any
mammalian genome), characteristics which classify it as a MAGE-D family
member

l6

(figure 2). The MHD region is extremely well conserved in the

MAGE-D subfamily and is partitioned on multiple exons, a unique feature of the
MAGE-D genes and suggestive of these genes being evolutionarily the earliest
MAGE genes 16. There is also a second, less well conserved MHD region
(denoted MHD2) which is only found in the MAGE-D family, E l and L2 genes.
NRAGE is a 775 amino acid protein with a molecular weight of about 87 kDa 13.
NRAGE

co-immunoprecipitates with

p75NTR when

both

proteins

are

endogenously- or over-expressed. NRAGE co-immunoprecipitates when the p75
ICD is aberrantly expressed, but NRAGE does not co-immunoprecipitate with the
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p75NTRC-terminal death domain on its own signifying that the death domain is
not responsible for NRAGE interaction

l3

.

mRNA expression of NRAGE is ubiquitous, from the early embryo and
extra embryonic tissues into adulthood. However, protein expression is highly
regulated both temporally and spatially and is found predominantly in the
developing brain

17.

Further inspection with antibodies against markers of

neuronal differentiation found that NRAGE was co-expressed with cells reactive
to neural and glial progenitor populations, as marked by NF-68 (neurofilament68) and GFAP (Glial Fibrillary Acidic Protein) respectively, but did not colocalize with the late-neural marker MAP2ah (Microtubule Associated Protein
2a/b). This demonstrates that NRAGE is originally expressed throughout the
neuroepithelium while later in development, expression is found in committed but
undifferentiated populations of cycling progenitors and is not expressed in postmitotic neurons susceptible to changes in neurotrophin expression

17.

This

temporally regulated expression is significant as neurotrophin-dependent survival
of neurons begins at around E l 6 and continues into adulthood, suggesting that
NRAGE expression can be an apoptosis effector of the neurotrophin pathway

13.

Notably, NRAGE was also expressed throughout the cerebral cortex where
p75NTRexpression was completely absent

l8

suggesting that NRAGE has

functions outside of p75NTRmediated signaling (further described below).
To clarify the downstream effects of NRAGE induced apoptosis, a series
of biochemical assays were performed to determine how NRAGE confers its
apoptotic effect. Upon NRAGE over-expression there are increased levels of

activated effector caspases 3 and 7

19.

Using a tetracycline-inducible NRAGE

adenovirus, cell death was rescued when broad spectrum caspase inhibitors BAF
or zFAD-fmk were added, collectively signifying NRAGE mediates cell death
through caspase activation

19

. Release of cytochrome c from the mitochondria,

brought on by active caspase 9 and APAF-1 complexing with cytochrome c, is a
key step in the apoptotic process20921.In NRAGE-adenovirus infected cells, high
levels of cytochrome c were detected in the cytoplasmic fraction indicating that
NRAGE over-expression can contribute in the release of cytochrome c from the
mitochondria. However this was not the result of activated caspase 9 because
cells treated with the caspase inhibitor showed an accumulation of cytochrome c
in the cytosolic fraction, indicating that cytochrome c is released from the
mitochondria in the absence of caspase activation 19.

This means that

mitochondria1 membrane depolarization and the release of cytochrome c under the
regulation of NRAGE are independent of the activation of caspase 9 and is not
required for the apoptosome to form19.

NRAGE's Role in Cell Proliferation and Differentiation
There is increasing evidence that misregulation of cell cycle molecules
and breach of cell cycle checkpoints is one possible mechanism for neural
progenitor and post-mitotic neuron- induced programmed cell death

22-25

.

Through BrdU incorporation assays, it was found that NRAGE over-expression
attenuates cell cycle progression in human endothelial kidney 293 cells

13, 26

NRAGE over-expression induced p53 expression as early as 24 hours post
transfection, and also induces activation of p21w"" and p27kip'within 24 hours,

maximally at 72 hours, indicating growth arrest at the G1-S transition within 72
hours of NRAGE over-expression

22, 26

. Apoptosis, as measured by Annexin V

staining was greatly attenuated when p53 was knocked down in P19 cells treated
with either Retinoic Acid (RA) or Bone Morphogenic Protein (BMP) suggesting
that p53 is a downstream participant of NRAGE-mediated apoptosis through
BMP activation 22. Using p53-null mouse embryonic fibroblasts, it was shown
that after 2 days of NRAGE over-expression, there is no change in cell cycle
kinetics suggesting that p53 is downstream of NRAGE-induced activity 2f Taken
together, these experiments demonstrate that NRAGE can act upon the cell cycle
by influencing the phosphorylation status of p53 which in turn mediates
downstream p21 ciplwaf and p27kip'activities on the cell cycle 22326.
Through Western blot analysis it was also seen that the level of
phosphorylated p38 was increased within the first 48 hours of NRAGE expression
then decreased precipitously at 72 hours 22. AS p38 is a downstream mediator of
TAKl -TAB 1 (TAKl: TGFP-Activated S n a s e , TAB 1: U K l binding protein)
induced BMP signaling, this implies that NRAGE is an indirect mediator of p38
activation. NRAGE over-expressing cells at 24 hours showed an increase in the
G2-M phase of the cycle, and at 48 hours most were either at G1 or in S phase
which was maintained at 72 hours, signifying an increase in cell cycle kinetics 22.
However, when a pharmaceutical p38 inhibitor was used, TAK dominant negative
construct overexpressed, or TAK morpholino expressed to knockdown
expression, NRAGE over expressing cells incurred rapid cell cycle arrest at G I ,
and this was sustained over the 72 hour period. Furthermore, a dominant negative

SMAD5 was co-transfected with NRAGE and as predicted, there was a cell cycle
arrest at G2, signifying a bipotential role of BMP-signaling through NRAGE 22.
Permanent withdrawal from the cell cycle is requisite for differentiation of
cells to mature phenotypes. As NRAGE was shown to influence the cell cycle
and over-expression can induce apoptosis, it is likely that NRAGE plays a role in
differentiation. As NRAGE over-expression is often lethal to cells, a morpholino
was utilized to knockdown NRAGE expression in P19 cells which were treated
with retinoic acid to induce neuronal differentiation.

Cells treated with the

NRAGE morpholino showed a drastic reduction in the number of post-mitotic
neurons as demonstrated by MAP2ah staining while the number of GFAP+ glial
cells remained constant. By contrast, the number of Nestin positive cells was
increased in NRAGE morpholino treated cells, evidence of the cells' inability to
terminally exit the cell cycle and differentiate into neurons

22.

Semi-quantitative

RT-PCR showed that it was not the inability of the cells to produce pro-neural
genes such as Mash1 in NRAGE knockdown cells, but rather there was a
maintenance of stem-like gene expression such as Oct4/5 and neural
differentiation antagonists Hesl and Hes5

22.

Overall, these data suggest that

NRAGE is required for the terminal exit of the cell cycle in neural progenitor
cells and a loss of cell cycle control can lead to NRAGE induced apoptosis
through a BMP dependent pathway which includes the downstream activation of
p38 22.

Necdin
Necdin is a type I1 MAGE gene 37-34
and is the closest homolog to NRAGE

35.

Maternal Necdin is silenced, and loss of paternal Necdin, most often through
abnormal imprinting, is associated with Prader-Willi syndrome, a neurobehavioural disorder characterized by respiratory distress and hypotonia in
neonates, and hyperphagia causing severe obesity, hypogonadism and behavioral
problems in childhood

36.

Over-expression of Necdin strongly suppresses cellular

proliferation by blocking entry into the cell cycle and can associate with cell cycle
proteins p53 and E2F1 to inhibit their activity, inducing cell cycle arrest in
progenitor cells. These interactions occur at Necdin's MAGE Homology Domain
and it has further been shown that Necdin can form homodimers through its
MHD. Because of these observations, the potential for interaction of Necdin and
NRAGE through their respective MHD to induce cell cycle arrest and/or
differentiation was investigated

'O.

Full length NRAGE and deletion mutants

which include the MHD were constructed and upon over-expression were show to
immunoprecipitate with ~ e c d i n " (figure 3). NRAGE binds to Necdin at the
MHD and NRAGE can also interact with MsxlIMsx2 at the repeat region,
resulting in a trinary complex

'O.

Both Msxl and Msx2 co-immunoprecipitate

with Necdin both in the presence and absence of NRAGE but could not associate
with Necdin with a mutation that can not bind to NRAGE. This suggests that
Msxl or Msx2 can bind to Necdin only when Necdin is able to bind to NRAGE
(likely a form of conformational change) 'O.
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Figure 3: Map of NRAGE with Corresponding Interactions with Adaptor Proteins.
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various proteins (identified as bracketed regions), Shown are the identified domains with the
~",
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To determine how this interaction affects cells, C2C12 muscle cells were
utilized because Msx2 can repress transcriptional regulation of myogenic
differentiation genes in these cells.

NRAGE over-expression released the

transcriptional repression effects of Msx2 potentially through a competitive
binding me~hanism'~. Necdin over-expression alone increased the expression
muscle differentiation genes MHC (myosin heavy chain) and MyoD each by a
factor of three. However, when Necdin and NRAGE were both over expressed,

MHC expression increased nine-fold and MyoD expression increased five-fold.
C2C12 cells naturally express NRAGE, so Necdin may augment the effects of
NRAGE in sequestering of Msx2, thereby releasing inhibition of the
differentiation of C2C 12 cells ".

However, a caveat to this data is that C2C 12

cells do not express Necdin at detectable levels, and there is no normal tissue that
has endogenously high levels of Msx and Necdin together, signifying that these
results may be strictly interpreted in vitro. Having said that, Necdin and NRAGE
may interact in other tissues as both are expressed in P19 cells, brain and skeletal
muscle. It may be that Necdin's influence on the cell cycle can be monitored by
NRAGE and that any inability of Necdin to prevent the cell from cycling may
trigger NRAGE to induce differentiation.

NRAGE is a Kev Mediator of the Neurotrophic Theorv
The neurotrophic theory outlines the role of target-derived neurotrophic

'

factors in regulation of cell survival during neural development (reviewed in 37).
As a direct result, the theory defines the role of apoptosis in neural development
as a necessary mitigating factor in the control of cell number and overall tissue
architecture

9.

Neurotrophic factors are the survival signals produced by the

target tissue (outlined below), and through their production, the target tissue
regulates the neuronal input it receives. This regulation can be accomplished in
three ways: regulation of production of neurotrophins; the regulation of their
secretion; or the limited uptake by pre-synaptic terminals (reviewed in

7).

The neurotrophins are a family of growth factors which include Nerve
Growth Factor (NGF), Brain Derived Neurotrophic Factor (BDNF), Neurotrophin
415 (NT415) and Neurotrophin-3 (NT3). Apart from regulating survial, these
growth factors also regulate dendritic and axonal growth as well as synaptic
activity

The neurotrophins also preferentially bind to pairs of growth factor

receptors termed Trk (Tyrosine Receptor Kinases) and p75NTR(Neurotrophin
Receptor). NGF preferentially binds to TrkA, BDNF and NT415 to TrkB and
NT3 to TrkC, and each of these can bind to the p75NTRas shown by coirnrnunoprecipitation when the proteins are over expressed

40, 41

. The Trks have

no sequence similarity to p75NTRand activate distinct neurotrophin-dependent
pathways but p75NTRdoes cooperate to increase the binding affinity of the
respective neurotropins to their receptors

42

and enhance NGF-mediated TrkA

activation 42-44.
p75NTRhas a significant role in cell death in a wide range of biological
settings within and beyond the nervous system. In vivo studies have shown that
over-expression of the intracellular domain results in widespread neuronal
apoptosis in the developing central and peripheral nervous systems

45 46

, .

Accordingly, a lack of NGF, disruption of the association of NGF to p75NTRin
cells, or mice lacking full length p75NTR(i.e. dominant negative receptor) results
in decreased apoptosis in the retina and spinal cord

46-50

. Furthermore, the Janus

N-terminal kinase (JNK) pathway is up-regulated upon initiation of NGF
dependent apoptosis, and pharmaceutical inhibition of JNK signaling
dominant-negative

" expression of

51,52

JNK attenuates NGF-dependent cell death.

or

The first investigation of NRAGE as a mediator of NGF-dependent death
was conducted. in MAH cells, an immortalized sympathoadrenal cell line. These
cells naturally lack p75NTRand TrkA receptors and do not apopotose when
stimulated with NGF even in the presence of exogenous expression of p75 NTR

44

.

Furthermore when NRAGE is over expressed, the cells show no increase in
apoptosis when stimulated with NGF, demonstrating that NRAGE was not
sufficient to mediate cell death in the absence of downstream receptor-mediated
NGF activation

13

. However, when MAH cells stably expressing p75NTRwere

transfected with NRAGE, there was a significant reduction of cell survival when
treated with NGF. Treatment with NGF also showed an increase of NRAGE at
the membrane suggesting that recruitment of NRAGE to the membraneFigure 4: p7sNTR-~ediated
Avovtotic
Signaline Cascade. p7sNTRmediates
the apoptotic signaling cascade through
NRAGE. Upon ligand activation,
NRAGE signals through the MAP
kinase pathway to phosphorylate JNK.
Upon JNK activation there is a release of
the apoptotic inhibitory molecules (such
as BH3 molecules Bim, Bad, and
JSM

SMACtDiablo) which in turn, facilitates
cytochrome c release and caspase
activation, ultimately resulting in
apoptosis (adapted from Barker, PA,

2004" j

associated p75NTRis required for the initiation of the apoptotic cascade. This
effect was specific to NGF, as neither BDNF nor NT3 induced cell death.
Overall, this shows that NRAGE expression is requisite to NGF-mediated cell
death through the p75NTRreceptor

13

. Conversely, when MAH cells were

exogenously expressing p75NTR,TrkA and NRAGE, and treated with NGF, there
was a rescue of cell survival, possibly through survival mechanisms mediated by
NGF

13.

Induced NRAGE expression activated the JNK pathway and activated

caspases 3, 7, and 9, as well as showing cytosolic accumulation of cytochrome c.
Blockage of the pathway at JNK and c-Jun reversed the effects on caspase
cleavage and rescued apoptosis

19.

Overall, these results demonstrate NRAGE is

a mediator of p75NTRsignaling through JNK resulting in caspase-mediated cell
death (figure 4).

UNCSH1
UNC5Hl is a membrane associated receptor that is the closest family
member to p75 NTR
Williams et a1

54

and is known to be involved in axon guidance and apoptosis.

" have shown that UNC5Hl

can also associate with NRAGE.

Through mutational analysis it was found that the C-terminal tail of NRAGE,
including the MAGE domain is necessary to interact with UNC5Hl while the ZU5 domain of UNC5Hl is required to interact with NRAGE specifically (figure 3).
This interaction occurs predominantly at the cell membrane ". TO understand the
functional consequences of these interactions, PC12 cells were used to determine
how these two proteins mediate neural differentiation. Native PC12 cells express

NRAGE at high levels but expression is significantly down-regulated upon
differentiation, coincident with the inability of LTNCSH 1 to co-immunoprecipitate
with NRAGE in differentiated PC 12 cells. Over-expression of UNCSH 1 in native
PC12 cells induced massive apoptosis but the percentage of apoptotic cells
diminished to neglible levels in differentiated cells. NRAGE transfection resulted
in a mild increase in apoptosis in differentiated PC12 cells, partially rescued by
over-expression of both constructs. Surprisingly, the over-expression of NRAGE
in differentiated PC12 cells caused the cells to retract their processes, in the
presence or absence of LTNCSHI suggesting multiple mechanisms of NRAGE
activity in the development of neural architecture ".

NRAGE's involvement in BMP-mediated Cell Death
Several reports have demonstrated that Bone Morphogenic Proteins
(BMPs) and their receptors are expressed in the developing brain

--.-56.57 .
7'3

The

temporal and spatial regulation of BMP signaling is highly regulated, as was
shown in two elegant experiments using chick embryos and cortical progenitors
56.57

. In chick embryos, high levels of BMP4 expression in even numbered

rhombomeres induces the expression of Msx2 in odd-numbered rhombomeres and
increases the rate of apoptosis of neural crest cells 56. In E l 3 rat cortical cultures,
BMP at IOnglmL shows substantial apoptosis. However, BMP treatment of E l 6
rat cortical cultures results in an increase in neuronal differentiation at the expense
of glial differentiation while not altering the percentage of undifferentiated cells

".

Delaying the addition of BMP4 to E l 6 cortical cells by three to four days

produces an increase in astrocytic differentiation, confirming the responses of the
cell to BMP stimulation are time sensitive 57. This suggests that at early stages of
neural development, BMP signaling is involved in patterning as well as apoptosis
and pruning of the neural precursor population, while at later stages it is involved
in pro-neural differentiation. Noggin, the BMP receptor antagonist, added to E l 6
cortical progenitors results in an increase of oligodendrocytes at the expense of
neurons,

suggesting

oligodendrocyte

that

BMP

differentiation

influence
and

cortical

promoting

cells

neuronal

by

inhibiting

differentiation.

Importantly, BMP2 protein is abundant in the E l 6 cortex and in the neonate, and
is present in the cortical plate and ependymallsubependymal region but absent in
the white matter and corpus collosum. These reports illustrate that BMPs are
essential in the developing brain to regulate brain cellular architecture through
patterning effects of cellular differentiation and apoptosis

'.

NRAGE protein expression increases significantly upon treatment with
RA and BMP4, a rise accompanied by an increase in activated caspase 3

22.

Through the use of morpholinos to knock down NRAGE expression, the loss of
NRAGE rescues the apoptotic effects of RA and BMP4 addition. Concurrently,
the NRAGE knockdown stayed the increase in caspase activation, signifying that
NRAGE is required for apoptosis in P19 and neural explants. NRAGE associated
with all three BMP receptors, weakly with the SMAD proteins but very strongly
with TAK1, TAB1 and XIAP, members of the non-canonical BMP pathway
known to activate downstream p38 but only in the presence of BMP4. The
phosphorylation status of p38 was increased in the presence of BMP4-stimulated

NRAGE, correlative with the level of TAKl, signifying that p38 activation is
downstream of NRAGE and TAKl and ultimately, BMP4 activation of receptor.
Abrogation of p38 activity through the use of the chemical inhibitor SB203580
resulted in a decrease in apoptosis (as seen by flow cytometry). This was also
confirmed though the use of a morpholino diminishing TAKl levels and a
SMAD5 dominant negative construct, demonstrating that both pathways are
required

for

NRAGE-mediated

BMP-induced

apoptosis

through

SMAD

Figure 5: Canonical and Non-Canonical BMP Signaling. Schematic diagram of BMP
signaling through the canonical SMAD adaptor proteins and the non-canonical pathway
mediated by NRAGE. NRAGE is hypothesized to form a complex with XIAP, TAKl and
TAB 1 to initiate p38 activation and downstream apoptotic responses (diagram courtesy J.
Verdi)

the

phosphorylation of p38 ".
Classical BMP signaling involves the members of the SMAD family of
co-factors, which are shared with the TGFP super family, of which the BMPs are
a subfamily. The canonical pathway involves SMAD 1, 5 or 8 complexing with
SMAD4, the co-factor, and the heterodimeric complex translocating to the
nucleus where it activates transcription

5 8 , 59.

SMADs 6 and 7 are inhibitors of

the complex and generally are signaled through a separate but parallel mechanism
to inhibit transcription. However, a second signaling pathway has been described
which utilizes XIAP as the bridge between TAB1 and TAKl and elicits
downstream events in the JNK, NLK and MAPK pathways

60.

TAKl is an

activator of TAB1, a member of the MAPKKK family and is stimulated upon
TGFPl or BMP4 activation

" and upon

over-expression can induce ventral

mesoderm formation (see figure 5).

XIAP
NRAGE was also identified through a yeast two-hybrid screen as a
binding partner for XIAP (X-linked Inhibitor of Apoptosis)

62.

AS a member of

the Inhibitor of Apoptosis (IAP) family, XIAP has an amino-terminal cystiene
rich baculovirus IAP domain (BIR) and a RING zinc finger motif. XIAP was
originally characterized as a protein that links the BMP receptors to downstream
TAKl and TAB1 and it had previously been shown that XIAP can bind to the
BMP receptors through its RING domain and to TAB1 via its BIR domain

".

XIAP can also interact with the nuclear protein XAF1, and SmacIDIABLO can
sequester XIAP to prevent its anti-apoptotic activity ""'.

Furthermore it has also

been implicated in JNK and NF-KB signaling

60,66.

NRAGE interacts with the

RING domain and not the BIR domain of XIAP (figure 3). 32D cells are a
promyeloid leukemic cell line, and a well established model for studying
apoptosis by growth factor withdrawal as they undergo high rates of apoptosis
upon Interleukin 3 (IL-3) withdrawal. When NRAGE is over-expressed, there is a
significant increase in the number of apoptotic cells upon growth factor
withdrawal, seen at a faster rate than with IL-3 withdrawal alone. Furthermore,
the increase in apoptosis upon NRAGE over-expression is co-committant with an
interaction of NRAGE with XIAP. Bcl-2 over-expression can rescue growth
factor removal induced apoptosis in 32D cells, however, upon NRAGE
overexposure, the effects of Bc12 over-expression are completely abolished and
cells undergo a similar rate of apoptosis upon IL-3 withdrawal 67. This signifies
that NRAGE and XIAP cooperate to induce apoptosis in 32D cells.

However,

the region to which XIAP interacts with NRAGE is not known, nor is it known
whether this interaction is required for apoptosis during neural development.
Understanding the region of NRAGE that is required for apoptosis, whether it is
through a mechanism with XIAP, upstream or downstream molecules remains to
be elucidated.

MsxIDlx
The mouse transcript of NRAGE was discovered through an interaction with
Dlx5, a member of the Dlx family of homeodomain proteins that are widely
expressed in the developing forebrain, limbs and branchial arches during
embryonic development 6"69 and is specifically expressed in developing bone and

induced in the process of bone fracture healing 68,70-73. In this study NRAGE was
identified in a yeast-two-hybrid screen and the 25 hexapeptide repeat of
WQXPXX of was identified as the region most likely to bind with the N-terminal
domain of D1x5 as this sequence was overlapping in all the clones identified

lS

(figure 3). Full length NRAGE and deletion mutants encoding the WQXPXX
region could immunoprecipitate with D1x5 as well as D1x7 and Msx2, other
members of the DlxIMsx homeodomain protein family

'O.

Both D1x5 and Msx2

are induced by BMP-signaling and Msx proteins are involved in neural
development

74

and in the BMP-mediated cell death pathway

23, 75

. Msxl and

Msx2 have been shown to be downstream regulators of BMP-mediated apoptosis,
and in P19 cells Msx2 over-expression can rapidly induce apoptosis only when
cells are in monolayer

75.

Importantly, BMP treatment of Msx2-expressing P19

cells did not augment apoptosis, signifying that over-expression was enough to
induce apoptosis but addition of BMP to native P19 cells did result in an increase
in Msx2 transcript

7',

possibly because the BMP pathway was saturated by Msx2

over-expression. However, unpublished data by Masuda et a1 ", indicate that
BNIP treatment of three cell lines including P19 did not alter the expression level
of NRAGE. Overall, these results indicate that BMP-mediated apoptosis through
Msx2 could be mediated by NRAGE. In situ data demonstrates that this may
occur in the bone or developing limb as well as in the brain, as was originally
described.

A Structure-Function Analysis of NRAGE is Warranted to Identify the
Functional Domains of the Protein
Published literature demonstrates that NRAGE can bind to a number of
varied binding partners and is associated with apoptosis in a number of
developmental and cellular contexts (summarized in figure 3). The majority of
these studies were borne of a yeast two-hybrid screen, which used a specific bait
to isolate NRAGE. The regions of NRAGE involved in the binding of these
proteins have not fully been characterized, especially in the case of XIAP and
p75NTR.Moreover the functional significance of these interactions have not been
characterized with respect to their actions within and upon the cell. Surprisingly,
the known interactors of NRAGE are also diverse in their own functions and these
studies indicate that NRAGE has more functions than apoptosis alone. Thus, a
structure-function investigation of the domains of NRAGE is warranted to
identify how NRAGE can interact and carry out its functions. Unlike the other
MAGE family members, MAGE-D genes have unique repeat regions as well as a
second less well-conserved MAGE homology domain. NRAGE has been shown
to interact with many molecules within apoptotic pathways but has since been
shown to be important in other cellular mechanisms as well. The repeat region of
NRAGE can associate with D1x5 and MsxlIMsx2, proteins involved in BMP
mediated apoptosis.

The MHD of NRAGE can interact with Necdin and

UNC5H1, both of which are involved in neural development however the
functional significance of these interactions remains elusive. XIAP, a member of
non-canonical BMP signaling pathway has also been shown to interact with

NRAGE, but like p75NTR,the region responsible for these interactions has not
been found (see figure 3 for a summary). Given the duality of NRAGE as a
regulator of the mitotic index and apoptosis; we sought to ascribe specific
NRAGE domains to these functions. We generated a series of deletion constructs
that target each domain, similar to the classical structure-function studies of Shc
76, TrkA 77, and NADE 78. TO test these constructs in a neural differentiation
paradigm, we utilized the P19 cell system to assess the roles of the individual
regions in apoptosis. Both the WQXPXX region and MHD regions are known to
interact with several proteins, thus our hypothesis is that these regions are
essential to NRAGE functions. Furthermore it is hypothesized that this region is
the region responsible for the downstream p38 activation and caspase cleavage
previously described as essential to NRAGE-mediated apoptosis upon BMP
stimulation. It was found that the repeat region is important but the MHD is
essential for NRAGE mediated apoptosis. These actions are mediated by p38 and
through which apoptosis is initiated through caspase 3 cleavage. Overall, these
studies will help to clarify the role of the identified regions of NRAGE and
ascribe functions to the regions and potentially to their binding partners as well.

Chapter 2

MATERIALS AND METHODS

NKAGE Deletion Clones
An adult ICR mouse brain was dissected free of meninges, washed twice
with sterile PBS, minced, homogenized and RNA isolated using the Trizol
reagent as per the manufacturer's protocol. cDNA was reverse transcribed using
the BioRad iScript reverse transcriptase and the reaction product diluted in 80pL
of nanopure water. Forward primers, where possible from the published sequence
(NM 019791), incorporated an endogenous methionine as a start site for
translation, a Xho restriction enzyme site, a Kozak sequence and start codon. The
reverse primer incorporated a Sal 1 restriction site (to facilitate subsequent
cloning) after the removal of the termination codon, which would generate a
fusion protein with eGFP in the pEGFP-N3 vector (Clontech). PCR reactions
were performed with the Taq DNA polymerase using 3.5mM MgC12, (Promega)
0.2pM of each primer, 0.2pM each nucleotide and lp1 of the diluted cDNA.
Primer sequence, extension times and melting temperatures are included in Table
1 and cloning strategy in Figure 6. Amplification products were run out on a 1%
agarose gel stained with lOOpg/ml ethidium bromide and excised from the gel
(PCR products are shown in Figure 7a). Each respective NRAGE fragment was

Table 1: Primers generated to clone NRAGE fragments and for diagnostics.

Melting temperatures of primers T,,

Annealing temperatures and extension times for PCR

reactions and nucleotide and protein predicted sizes are included.

Name

Sequence

T,
("C)

Annealing
Temp
with R2
("c)

Extension
Time

Fragment
size with
R2 bp (kDa
incl.GFP)

F1

GAG ACG CTC GAG ATG GCT CAG
AAA CCG
AGT GCC CTC GAG ATG CCA AAC
AAC CAG
GTG ACC CTC GAG ATG GAC CCA
CCT GGA GCA
TGG CCA CTC GAG ATG GCC TGG
CAG AGT ACA
GAC TGG CTC GAG ATG GGA CCC
TCA CCT AAT CTG
AAG CGC CTC GAG ATG GTG AGG
GAT ATC ATC

64

55

2.5 min

2328 (1 16)

64

55

2 min

1810 (96)

69

55

2 min

1486 (84)

69

55

1.5 min

1220 (74)

66

55

1.5 min

1010 (66)

64

55

1 min

845 (59)

F2
F3
F4
F6
F7

(F1)MAQKPDGGAGLRGFQAEASVEDSALLVQTLMEAIQISEA
PPTSQATAAASGPNASPQSSQPPTANEKADTEVSAAAARPKTG
FKAQNATTKGPNDYSQARNAKEMPKNQSKAAFKSQNGTPKGPH
AASDFSQAAPTGKSAKKSEMAFKGQNSTKAGPGTTYNFPQSPS
(F2)ANEMTNNQPKTAKAWNDTTKVPGADAQTQNVNQAKMADV
GTSAGISEADGAAAQTSADGSQTQNVESRTIIRGKRTRKVNNL
NVEENNSGDQRRASLASGNWRSAPVPVTTQQ(F3)NPPGAPPN
VVWQTPLAWQNPSGWQNQTARQTPPAARQSPPARQTPSAWQNP

VAWQNPVIWPNPVIWQNPVIWPNPIVWPGPIVWPNPM(F4)AW
QSTPGWQSPPSWQAPPSWQSPQDWQGPPDWQVPPDWS(F5)MP
PDWSFPSDWPFPPDWIPADWPIPPDWQNL(F6)RPSPNLRSSS
NSRASQNQGPPQPRDVALLQERANKLVKYLMLKDYTKVPIKRS
E(F7)MLRDIIREYTDVYPEIIERACFVLEKKFGIQLKEIDKE
EHLYILISTPESLAGILGTTKDTPKLGLLLVILGIIF(F8)MN
GNRATEAVLWEALRKMGLRPGVRHPLLGDLRKLLTYEFVKQKY
LDYRRVPNSNPPEYEFLWGLRSYHETSKMKVLRFIAEVQKRDP
RDWTAQFMEAADEALDALDAAAAEAEARAEARNR ( R1) M ( F 9 1
GIGDEAVSGPWSWDDIEFELLTWDEEGDFGDPWSRIPFTFWAR
YHQNARSRFPQAFTGPIIGPSGTATANFAANFGAIGFFWVE(R

Construct in pEGFP-N3

.?

cloned into the pCR-BluntII-TOP0 vector using the TOPO isomerase ligation
reaction, chemically transformed into Top10 supercompetent cells (as per
manufacturer's

instructions; Invitrogen) and plated onto LB-agar plates

supplemented with 50pglml kanamycin. Random clones were grown overnight in
LB media supplemented with kanamycin and plasmid extracted using the
Eppendorf fast plasmid mini prep kit. 2pg of plasmid were digested with Xhol
for validation and orientation of insert and grown in 125ml cultures for midi
plasmid preps. Glycerol stocks were stored for future use. Nested PCR was also
performed using the F(x+l) primer and R l to determine whether the product
inserted was able to be amplified using internal primer sites.
As there is a Xho site adjacent to the TOPO PCR product insertion site,
we instead elected to use the Sacl restriction enzyme which cut upstream of the
PCR insertion site. 1Opg of the NRAGE FxR2-TOP0 vectors and pEGFP-N3
were digested sequentially with Sacl then Sall, as recommended by New
England Biolabs. Reaction fragments were isolated in a 1% agarose gel stained
with 100pgIml ethidium bromide and DNA excised from gel fragments by the
QIAquick gel extraction kit (Qiagen

-

as per manufacturer's instructions).

Ligation of the digested NRAGE fragments into the pEGFP vector was performed
in 15pl reactions with lpl of T4 DNA ligase (NEB) overnight at 14°C then
electroporated into TOP10 electrocompetent bacteria and plated on LB-agar
plates with 50pglml kanamycin. Random colonies were picked, plasmid isolated,
and digested with Sac1 and SalI to determine correct integration. Representative
constructs (Fl, F2, F3, F4, F9lR2-GFP) were sequenced to determine proper

integration into the GFP vector and the framing of the NRAGE fragment into
eGFP, using the pEGFP diag F primer to sequence into the multiple cloning site
and the NRAGE F9 primer to sequence out of the NRAGE fragment and into the
GFP vector.

Cell Culturing and Transfections
Human cell lines HEK 293 and N2A were maintained in DMEM
(GibcoBRL) supplemented with fetal bovine serum (10% final concentration;
Hyclone) and l x antibiotic/antimycotic (100x stock solution; GibcoBRL).
Murine P19 cells were grown in aMEM, supplemented with calf serum (7.5%
final concentration), fetal bovine serum (2.5% final concentration) and
antibiotic/antimycotic according to Jones-Villeneuve et al.

79

. All cells were

grown at 37°C at 5% C02. P19 cells were fed every day and passaged at a 1:10
ratio every other day. 293 cells were fed every other day and passaged 1:10 every
third or fourth day.
Transfections were performed in 6 well dishes at 70-80% confluency.

In

individual tubes, 8yg of DNA and lop1 of Lipofectamine 2000@ (Invitrogen)
were diluted in 250yl of serum free DMEM each for 5 minutes then the DNA
added to the Lipofectamine mixtures and incubated to allow the DNA:liposome
complexes to form.

Cells were washed with serum free media then the

transfection mixture added with 1.5 ml serum free media. Cells were incubated
for 4-6 hours at 37°C before the removal of transfection mixture and the addition
of serum-containing media. Expression was assayed 24 hours post transfection

using a Leica epifluorescence microscope at 50x magnification.

Controls

included the native pEGFP-N3 construct and mock transfections to assess
efficiency. Efficiency was evaluated by estimating the number of fluorescent
cells per field in comparison to the pEGFP-N3 transfections.
For P19 cell transfections, a confluent plate of cells were passaged 1: 10 on
day 1, transfection mixture was added as described above on the morning of day 2
and six hours later an equal volume of media containing twice the concentration
of serum was added, without removing the transfection mixture. 24 hours later
(48 hours post split) cells were washed and standard PI9 media added and
fluorescence analyzed by fluorescence microscopy before analysis by flow
cytometry where appropriate. Transfection efficiencies were in the range of 3060% with the longest NRAGE constructs giving consistently lower efficiencies,
while expression intensity of the plasmids remained consistent across all
constructs.

Cell Lvsates and Western Blotting Procedure
Cells were aspirated free of media, washed with ice cold PBS, and
mechanically detached from the plates. Cells were collected and spun at 15OOrpm
for 3 minutes before removing PBS and addition of 500pl RIPA buffer (150mM
NaCl, lOrnM Tris, pH 7.2, 0.1% SDS, 1% deoxycholate, 5mM EDTA)
supplemented with lpm sodium orthovanadate, lpm sodium flouride and protease
inhibitor cocktail (Sigma: 104mM AEBSF, 80pM aprotinin, 2mM leupeptin,
4mM bestatin, 1.5mM pepstatin A, 1.4mM E-64). Lysates were incubated on ice

for 20 minutes before relative concentrations determined using the BCA protein
assay kit using a round bottom 96-well dish according to manufacturer's
instructions (Promega). The lowest mean protein concentration sample was used
for the largest volume with the equal amount calculated for subsequent samples.
For a 12 well comb, lOOpl was loaded (not including 2x loading buffer), a 15 well
comb, 75p1 of lysate and for a 20 well comb, 50p1 of lysate.
Protein samples were run on a 10% acrylamide gel overnight at 50 volts
and the gel transferred to nitrocellulose membrane (Amersham Biosciences). The
transfer was performed in a glycine-based submersion buffer for 2 hours at 0.5A
at 4°C. The transfer membrane was washed in TBS 1% Tween (TBST) then
blocked in TBST with 5% BSA (BSA+TBST) (for phospho-specific detection) or
non-fat dry milk for 1-2 hours.

Antibodies were added at appropriate

concentrations (see Table 2) in milk or BSA+TBST overnight at 4°C. Membranes
were washed in TBST three times for 15 minutes each prior to the incubation of
the appropriate HRP-conjugated secondary antibody at a 1:10,000 dilution
(BioRad) and strep-tactin conjugated HRP at a 1:5000 dilution (for the Precision
Plus Molecular Ladder, when appropriate) for 45 minutes at room temperature.
The membrane was subsequently washed by at least three 15 minute incubations
and drained of fluid. Equal parts of the enhanced chemiluminescent (ECL)
substrate solutions were mixed and washed over the membrane for 1 minute then
the membrane dried to remove puddles and developed using Sensitive Blue X-ray
film (Pegasus Scientific) and the in-house X-ray developer.

Molecular rulers

were either the Precision Plus blue stained ladder or the broad range ladder (both

BioRad). NRAGE deletion constructs were immunoblotted for the GFP tag as the
epitope for the commercially available NRAGE antibodies were removed in
generating the constructs.

Table 2: Antibodies: their source, dilution and application.
Antibody, clone
number
GFP
P38
p-p38
Activated
Caspase, Asp 175
(5A1)
Annexin V-PE
(36)
7AAD
Actin

Company,
catalog number
Santa Cruz
Cell Signaling
9212
Cell Signaling
921 1
Cell Signaling
9964

Dilution

Species

Application

1: 1000
1:1000

Rabbit
Rabbit

WB
WB

I: I000

Rabbit

WB

I: I000

Rabbit

WB

BD Biosciences
5 1-65875
BD Biosciences
51 -68981
Sigma, A2228

1:100

Preconjugated

FC

1 :100

Preconjugated

FC

1:1000

Mouse

WB

Legend: WB: Western blot, FC: flow cytometry

Flow Cytometry Analysis of Apoptosis
Three independent transfections were analyzed by Annexin V and 7AAD
staining to determine the rate of apoptosis. At 48 hours post-transfection, cells
were trypsinized to detach from the plate and spun at 1200 rpm for 3 minutes to
pellet. lop1 of suspension was taken and cells counted using a hemocytometer to
determine the number of cells per ml. Cells were diluted to 1 million per ml in
Antibody Binding Buffer (0.1M HepesINaOH pH 7.4, 1.4M NaC1, 25mM CaC12
diluted 1:10 in sterile water) included in the apoptosis detection kit (BD
Biosciences). For controls, lOOpl of cells were placed in 5ml culture tubes with
5pl of either Annexin V-PE or 7AAD or both and incubated in the dark for at

least 20 minutes (see Table 2). 250p1 of sample cells were incubated with 15p1 of
each apoptosis marker for at least 20 minutes in the dark. Upon completion of the
incubation period, cells were diluted in 400p1 (control) or 750p1 (sample) of
binding buffer and analyzed by flow cytometry using the Becton Dickinson FASC
Calibur flow cytometer and Cell Quest software version 3.3. GFP+ cells were
gated and cell incorporation of Annexin V and 7AAD determined in a sample size
of 5000 cells. Gates were determined using untransfected and unstained cells.
GFP and PE were excited by the Argon 488 laser and GFP read on the FL1
channel and PE on the FL2 channel. Compensation was set at 25.8% of the FL1
channel to reduce bleed-through of the GFP signal into the PE channel. All data
was plotted in the log mode. Statistics were performed using Microsoft Excel
Data Analysis Software. ANOVA was performed to determine the statistical
validity of the series of constructs and two tailed t-test performed for the
statistically significant pairings.

Chapter 3

RESULTS

The structure of NRAGE and the dissection of the protein
The domains of NRAGE were identified in the protein sequence and
whenever possible native methoniones were used as start codons for the construct.
Nine constructs were designed to be generated with two reverse primers. The
forward primers (Fl-F9) were designed upstream to the start of the region of
interest while the R1 primer was designed to begin amplification at the end of the
MAGE homology domain (MHD) and R2 to the end of the protein coding
sequence. Fragments F1-F9lR2 were first cloned with constructs Fl-F4lR2 and
F6-F91R2 successfully generated.

F8R1 was also cloned for subsequent use.

FIR2 encodes the complete NRAGE coding sequence while F2R2 takes off the N
terminal sequence until the beginning of the NIHD2. F3R2 encodes a protein
which begins after the MHD2 region ends. F4R2 and F5R2 each remove sections
of the WQXPXX domain while F6R2 removes almost the entire WQXPXX
domain. F7R2 and F8R2 delete regions of the MAGE homology domain while
F9R2 only encodes for the extreme C-terminal end of the protein with no
identified regions. F8R1 encodes for the second half of the MHD (schematic
diagrams in figure 6, PCR products in 7a and Western blot in figure 7b).

Cloning Strategy of NRAGE Constructs
The forward primers were designed with a Xhol restriction digest site 5'
to a designed Kozak sequence and start codon. Reverse primers deleted the stop
codon and added a Sall restriction digest site which was all in frame to the
pEGFP-N3 vector (Clontech). PCR products were generated from cDNA derived
from adult mouse brain RNA. Products amplified matched predicted sequence
sizes and were cloned into the TOPO cloning vector as per manufacturer's
instructions. As the TOPO vector was not in the original cloning strategy it was
subsequently discovered that there is a Xhol site near the 3' PCR product
insertion site so digestion of the constructs with Xhol proved problematic.
However, digestion with Xhol allowed us to determine in which orientation the
PCR product was inserted into the vector as the products were either the predicted
fragment size or essentially linearized. Therefore, Xhol was used as a diagnostic
digest to 1) determine if the PCR product was in the vector and 2) which
orientation the fragment inserted.

Plasmids were digested and ligated into

pEGFP-N3 and colonies digested to ensure correct fragment size. Representative
constructs were also sequenced to ensure correct sequence. Constructs were
transfected into 293 and N2A cells and showed expression by GFP and upon lysis
and Western blotting, displayed immunoreactive protein at the predicted protein
sizes (for fragment + GFP sizes, see table 2; Western blot, figure 8).
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Figure 8: NRAGE Fragments are expressed in N2A and HEK293 Cells. N2A
neuroblastoma cells and HEK293 cells were transfected with the NRAGE constructs and
lysed after 24 hours. Shown are equivalent amounts of protein loaded on a 10% acrylamide
SDS-PAGE gel electrophoresis and transferred onto a nitrocellulose membrane. The
membrane was blotted with an anti-GFP antibody and developed using X-ray film. FIR2
did not transfer. Molecular weight standards are on the Y-Axis.

Description of the PI9 Cell Model System
P19 cells were used as the model system of this study for two main
reasons.

P19 cells are a murine embryonal carcinoma cell line isolated by

McBurney and colleagues
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that can produce a multitude of cell types under

various differentiation conditions.

Importantly, when cultured in suspension

M
acid for four days then grown on tissue culture
supplemented with ~ o - ~retinoic
treated plates, they can produce neurons within 4 days of plating, and smooth
muscle cells and oligodendrocytes within another 4 days. Furthermore, these
cells have also been shown to differentially express neurotrophins and have been
used as a model system to study neurotrophin responsiveness in neural
development

Because of these properties, P19 cells have become an accepted

cell line to study the development of the nervous system and more specifically the
molecular regulation of neurogenesis.

P19 cells were transfected with 0.4pg

DNA and lpl Lipofectamine 2000 per cm surface area of plate over a 24 hour
period and transfection efficiency was determined by fluorescence of the GFP tag
through fluorescence microscopy and Western blotting.

NKAGE Constructs Cause Differential Apoptosis
One goal was to identify the region of NRAGE responsible for the
apoptotic events during neurogenesis.

Deletion constructs generated above

isolated the recognized domains of the protein as well as fragmented the regions
in an effort to determine a minimal region necessary for apoptosis. Previous data
in P19 cells show that full length NRAGE can induce apoptosis within 24 hours

and reproducibly at 48 hours

22.

Addition of BMP can accelerate this timeline to

reproducibly at 24 hours, however we elected to wait the 48 hours to assay for
apoptosis in order to demonstrate the true behaviour of NRAGE without
supplementing with BMP. Thus, 48 hours after transfection, cell death was
determined by Annexin V and 7AAD uptake by flow cytometry. Staining of three
independent transfections showed a precipitous decrease in apoptotic cells
transfected with Fragment 7, the fragment that does not contain any of the
tryptophan-repeat region and part of the MHD (figure 9) and subsequent
constructs

F8R2

and

F9R2

(ANOVA

p=5.2

x

10.'~).

Apoptosis by Annexin V

GFP

FIR2

F2R2

F3R2

F4R2

F6R2

F7R2

F8R2

F9R2

Construct

Figure 9: NRAGE constructs show differential apoptotic activity. Statistical analysis of the
apoptotic potential of the NRAGE constructs in P19 cells. At three separate occasions, P19 cells
were transfected with the NRAGE constructs, and 48 hours after transfection, were live stained
with Annexin V-PE and analyzed by flow cytometry. Cells were gated for GFP+ cells and the
presence of Annexin V-PE was read above a threshold determined by controls (single stained
and unstained cells of GFP+ and untransfected cells). Statistical p-values are shown for the
statistically significant construct pairings (further discussed in materials and methods and
results).

There is, however, a significant increase (p=0.01) in cell viability upon the
expression of F6R2 signifying that the end of the WQXPXX region and the
beginning of the MHD does contain some apoptotic response. However, levels of
cellular apoptosis returns to control levels with removal of the entire repeat region
and some of the MHD as in construct F7R2 (F6R2-F7R2 p=0.0009; F4R2-F7R2
p=0.007).

NRAGE Deletions Show Altered Caspase and p38 Activation
Caspase 3 is a member of the executioner subfamily of caspases and as
such is a broad-spectrum indicator of apoptosis. NRAGE has been shown to be
involved in caspase-mediated activation and specifically caspase 3 cleavage, thus
Western blot analysis was used to determine which fragments of NRAGE can
mediate caspase activation. P19 cells transfected with the NRAGE constructs
were lysed in RIPA buffer and subjected to Western blotting

and

immunodetection with an activated caspase 3 specific antibody. Presence of
cleaved caspase 3 was detected in cells over expressing F1R2 and F2R2
constructs. Caspase activation remained constant but decreased by about half
with constructs F3, F4, F6 and F7R2 while no activated caspase was detected with
F8R2, F9R2, and F8R1 signifying that these constructs can not mediate caspase
activation (figure 10a). This is in partial agreement with the Annexin V staining
described above, crediting constructs F l through F6 with the initiation of
apoptosis. However, this is in opposition to flow cytometry data, as these data

show that F7R2 can initiate caspase cleavage however no appreciable level of
apoptosis is seen by Annexin V.
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Figure 10: NRAGE deletion show altered caspase and p38 activitv. A: PI 9 cells were
transfected with the NRAGE constructs and lysed at 48 hours after transfection. Equal
amounts of lysates were run on a 10% SDS-PAGE gel and immunoblotted to nitrocellulose
membrane. Shown is an immunoblot analysis of cleaved caspase 3 from P19 cells. No
cleaved caspase 2 could be deteced from F8R2 through pEGFP signifying a loss of caspase
activity associated with apoptosis.

Separate aliquots of cell lysates from the preparation

described in figure 10A were simultaneously electrophoresed an immunoblotted with anti-p38
antibodies. Upper panel shows phospho-p38 staining with signal diminishing to control levels
at F8R2 while total p38 (lower panel) remained consistent. Presented here is the best of two
attempts, the left side of the membrane did not transfer efficiently.

The phosphorylation of p38 is a significant event in the NRAGE mediated
apoptosis pathway and has been shown to be activated in both the presence and
absence of BMP. P19 cells were transfected with the NRAGE-GFP constructs
and lysed for SDS-PAGE analysis.

Through the use of phosphate specific

antibodies, it was found that p38 is phosphorylated in constructs F1-F7 while

constructs F8R2, F9R2 and F8R1 show similar levels of phosphorylation to GFP
control and in comparison to total p38. This signifies that the WQXPXX and the
second half of the MHD are capable of downstream p38 activation, however the
second half of the MHD is not sufficient to induce phosphorylation, as the F8R1
construct which encodes the C terminal portion of the MHD can not induce
phosphorlyation on its own (figure lob).

NRAGE Constructs Show Differential Sub-Cellular Localization
It is well documented that upon cleavage, MAGE protein localization can
be altered, as the type I MAGE protein's MHD is transported to the cell surface to
be the antigen of the major histocompatibility complex (MHC)

!'

A structure-

function analysis of Necdin also showed subcellular localization differences in
gene fragments not encoding regions of the MHD

'I.

To further investigate

whether our NRAGE fragments showed differences in subcellular localization, we
transfected the GFP-tagged constructs into various cell types to discern
differences in sub-cellular localization. Upon inspection of the fluorescent activity
of the NRAGE-GFP constructs, it was found that the constructs displayed a wide
variety of subcellular localization patterns that were consistent across cell types
[HEK 293 cells, N2A cells, P19 cells, as well as mIMCD3 cells, a mouse kidney
epithelial cell line (personal communication, G. Nikopoulos)]. Figure 11 shows
the subcellular localizations of the fragments in PI9 cells which were consistently
bright at 12 hours but the largest constructs decreasing fluorescent activity
significantly at 24 hours. Constructs FlR2, F2R2 show diffuse staining in the

cytoplasm while being excluded from the region of the nucleus. Constructs F3R2
through F8R2 and F8R1 show some cytoplasmic fluorescence but large focal
points of fluorescence are observed in cytoplasmic regions, consistent with being
in a subcellular structure such an aggresome or apopotosome. Fragment F9R2
appears to be diffusely detected in the cytoplasm with no focal expression. This
suggests that the WQXPXX region and the MHD, the regions involved in proteinprotein interactions permit intracellular aggregation while the MHD2 regions and
the extreme N and C terminal portions oppose these abilities. Interestingly, no
construct seemed to localize to the membrane, which is significant as the type I
MAGEs are proteolytically processed and presented on the cell surface and
NRAGE is known to interact with several membrane bound proteins (p75NTR,
UNC5H1, BMPR). This suggests that cell stimulation by appropriate ligands may
be required for membrane and/or receptor localization.

Chapter 4

DISCUSSION

This project was undertaken to give identity and function to the
identifiable regions of the NRAGE protein. NRAGE is a member of the MAGE
family of proteins, and as such has one highly conserved MAGE Homology
Domain (NIHD), one less-well conserved domain, denoted MHD2 and a unique
25 tandem WQXPXX tryptophan repeat region. The literature gives no definite
function to the MHD of NRAGE however, several proteins have been shown to
interact and have binding capacity to both the MHD and WQXPXX regions (see
figure 3). It has also been demonstrated that repeat regions in general have
possible binding capabilities. The trypotphan-rich region certainly has potential
for binding as it is presumed to be 'sticky' and has a hypothetical binding-friendly
confirmation. No NRAGE mutant mouse has been described (either transgenic or
knockout) and previous cloning experiments have been restricted to the
description of novel binding interactions.

Moreover, it is only recently that

NRAGE has been shown to interact with the non-canonical BMP-signaling
pathway.

Although NRAGE was originally cloned as a p75NTRintracellular

domain interactor, the domain of NRAGE responsible for interactions with either
p75NTRor the BMP receptors have not been characterized. Thus, an extensive

cloning strategy was designed to isolate the various regions of NRAGE and an
analysis of the apoptotic cascade in reference to the mutant constructs performed
to isolate the region responsible for apoptosis and confirm its effects on
downstream signaling cascades.

The NRAGE MHD is Required for Apoptosis
The published literature shows that of the known molecules that interact
with NRAGE, one third have been show to interact with the WQXPXX domain,
one third to interact with the MHD and the interactions of the remaining
molecules have not been characterized. Thus our hypothesis was that the region
that was responsible for apoptosis was either the MHD or the hexapeptide repeat
region. The MHD is the region most conserved across all MAGE genes yet very
few of the MAGE genes have been functionally characterized; NRAGE and
Necdin are notable exceptions.

Mutations in the paternal necdin locus (the

maternal gene is silenced) are thought to be at least partially responsible for
Prader-Willi syndrome, a developmental disorder that affects the brain.
Molecularly, Necdin is highly expressed in post mitotic neurons and is thought to
play a major role in preventing the neuron from re-entering the cell cycle. The
MHD of the type I MAGE genes is the region that is presented within the major
histocompatibility complex (MHC) of tumor cells to signal a cytotoxic T cell
response and subsequent tumor rejection. However, the intracellular processing
of the protein for presentation in the MHC has not been identified and as such,
little is known about the protein. Yet even with these discoveries, the MHD7s

function(s) has not been conclusively documented, nor trends been seen. This is
the first evidence of a definitive role of the MAGE domain in any cellular
function.
The WQXPXX region was the other region that may have been involved
in the apoptotic response. Repeat regions of proteins are important for proteinprotein interactions and all MAGE-D genes have a repeat region, although there is
no homology to one another. Proteins that have been shown to interact with this
region of NRAGE have also been identified as downstream mediators of BMP
signaling, thus it was reasonable to hypothesize that this region was required for
downstream BMP mediated apoptosis. As all MAGE-D family members have a
unique tandem repeat region, it may be that this region is important for
interactions with partners rather than having a universal function shared among
the MAGE-D family members.

Although this region, through its binding

interactions, could be requisite for NRAGE apoptotic functions, these
experiments suggest that this is not the case.
Western blotting data confirmed the flow cytometry data that the MHD is
essential for apoptotic function however these results showed that the first half of
the domain can also induce caspase and p38 activation. Although a significant
decrease in apoptosis was seen by Annexin V staining at F6R2 (p=0.01) and
essentially no apoptosis detected with constructs F7R2 through F9R2, this only
reiterates the necessity for the MHD in cellular apoptosis. XIAP is a member of
the non-canonical BMP signaling pathway and is a highly conserved apoptotic
molecule. Where XIAP binds to NRAGE has not been identified. It can be

surmised that NRAGE interacts with XIAP at the MHD as this region seems to be
important in cell death.
The result of the MHD being required in apoptosis was somewhat
surprising for two reasons. First, the MAGE homology domain is the most well
conserved and thus is most likely to have an evolutionarily essential function
(such as inducement of apoptosis).

So far, the other MAGE genes have not

shown to be involved in apoptosis, it seems unlikely that this region would be
implicated in yet another function. Apoptosis is a highly dynamic process with
many proteins participating in a highly conserved cascade. If it is true that the
MAGE-D genes are the most evolutionarily conserved, it would be surprising that
these genes and especially the MHD would have diverged to perform another task
from cell cycle withdrawal or MHC. Secondly, the suspected adhesive properties
of the tryptophan repeat region was hypothesized to be important for the
recruitment of co-apoptotic molecules.

Indeed, molecules shown to be

downstream of one of the major NRAGE- mediated apoptotic pathways interact
with the repeat region.

Although there is a decrease in apoptosis when the

majority of the repeat region is lost, reduction of apoptosis to basal levels only
occurs once a significant portion of the MHD as well as the entire WQXPXX
region is deleted. This begs for speculation to what the MHD does to or interacts
with to be so critical for programmed cell death. One yeast-two-hybrid screen has
been performed with the MHD which isolated two proteins, one of which is
important for NRAGE turnover however a second one using a neural
development-specific library may uncover new interactors to the MHD

specifically. Future studies currently underway will determine whether XIAP
binding to NRAGE occurs at the tryptophan-repeat region or the MAGE
homology domain, and where these interactions occur within the cell.

NRAGE Fragments are Differentiallv Localized Within the Cell
It was observed, upon inspection of GFP fluorescence, that the NRAGE
fragments are differentially localized within the cell. This is consistent across cell
types within the neural lineage (N2A, P19), across species (mouse P19, human
N2A and HEK293) and across cell types (mIMCD3 epithelia, HEK293
endothelia, N2A neuroepithelia). Full length NRAGE is consistently detected in
the cytoplasm while mutant constructs generated in this study that express regions
of the WQXPXX and MHD regions are detected peri-nuclear and in subcellular
compartments. F9R2, the construct missing the entire MHD, does not give such a
punctate staining pattern. A Necdin structure-function analysis showed similar
variant expression patterns, with protein generally detected both in the cytoplasm
and abundantly in the nucleus

81.

Constructs missing portions of the MHD are not

associated with the nucleus, rather are associated within the cytoplasm as
speckles. Based on the observations of Taniura ", it could be hypothesized that
the MHD is the region of NRAGE that confers the sub-cellular distribution,
however due to the design of our constructs, the only fragment that does not
contain the MHD is F9R2.
The speckled appearance of certain NRAGE constructs raises questions as
to why the protein is aggregated and with what it associates. The apoptosome is a

conglomerate of APAF1, ATP, and caspase 9 and cytochrome c when released
from the mitochondria.

XIAP is associated with the apoptosome to prevent

abberant pro-caspase 9 cleavage and NRAGE can interact with XIAP. Although
the kinetics and biochemistry needs to be tested, it could be that these specific
NRAGE fragments show differential binding to the components of the
apoptosome and as such, can aggregate. However this aggregation may not be
within the apoptosome but as part of an aggregate in general. It does not seem
like the fragments aggregate through the WQXPXX region, as constructs missing
this region still show a punctate staining pattern and the C terminal portion of the
protein (and the GFP tag alone do not self-aggregate) so it may be assumed that
the MHD is involved in the accumulation of the protein. This is in agreement
with Taniura

who also saw an aggregation of protein with constructs expressing

the MHD. Little is known about the MHD, however further deconstruction of
NRAGE by deleting the MHD while retaining the rest of the protein would
confirm these results as well as further investigate the role of the MHD overall.
MAGE genes are cytoplasmically processed in the golgi and the MHD is
presented as the antigen of the MHC. There is no published literature of NRAGE,
or any of the other MAGE-D family members being cleaved and presented as the
MHC, however this is theoretically possible. Thus, the pattern of fluorescence
aggregation may be a result of the MHD being sequestered into lysosomes for
proteolytic processing. This pattern is observed in cells with constructs lacking
the N terminal portion of the MHD2. No function has been described for the less
well conserved MHD2, which is present in all MAGE-D proteins and some other

type 2 MAGEs. It is possible that the NIHD2, or a portion thereof is responsible
for preventing the proteolytic processing that would present the MHD on the cell
surface. However, it is important to note that there was no detectable expression
at the cell surface signifying that the MHC may not be functional in these cells or
that the proteolytic process was not completed, due to a lack of proteins involved
or the functionality of NRAGE itself. These experiments were done with the use
of an epifluorescence microscope, confocal microscopy should be used to confirm
these results as well as more accurately determine if the proteins are aggregating
at an organelle.

The C-terminal MHD is Essential for Caspase and p38 Signaling
Western blot analysis of the NRAGE constructs yielded surprising results
when compared to the Annexin V flow cytometry data. As discussed above,
Annexin V staining, corroborated by 7AAD staining (not shown) indicates that
there is a precipitous decrease of apoptosis with the F6R2 construct which deletes
the WQXPXX region but over-expression of the F7R2 construct, which deletes
the first half of the MHD, restores cell survival. However, both caspase and p38
activation can occur in the absence of the N-terminal half of the MHD but only
when the construct contains the extreme terminus of the protein. There are
several reasons why these seemingly incompatible data can be explained. First,
there may be an as of yet another unknown signaling pathway cooperating with
the NRAGE-caspase 3 pathway to mediate the apoptosis cascade. In the absence
of the first half of the MHD, caspase 3 can be activated, possibly through a p38

mediated response however apoptosis as measured by Annexin V is not apparent.
This second signaling pathway may interact with the N-terminal portion of the
MHD, thus when removed with F7R2, it can not interact to perform its function.
Indeed, this may be the region to which XIAP interacts, however future
experiments are being designed to address this. Second, data also shows that the
caspase 3 and p38 activation response only occurs when the C-terminal portion of
the MHD and its subsequent unconserved region remain intact. Although the
Annexin V experiments did not include the F8RI construct, it can be
hypothesized that, based on Western blot data, the F8Rl construct would show no
increase in apoptosis.

This could be due to a conformational change in the

folding of the MHD of F8R1, thus rendering it useless. However, this could also
be due to incomplete binding of a protein which requires another protein to
properly interact with NRAGE.

NRAGE is widely accepted as an adaptor

molecule for the various signaling pathway in which it interacts, this adaptor
function may be as an accessory for docking.

However, as stated above,

significant further study needs to be completed to adequately explain why p38 and
caspase activation does not structurally correlate with functional apoptosis assays.

NRAGE has been described as an apoptotic molecule in both BMP and
NGF mediated signaling. The experiments reported here were completed in the
presence of serum, which likely has some level of BNIPs as well as neurotrophins.
Considering the high levels of apoptosis in these pro-survival growth conditions,
it is unlikely that the supplementation of the media of either growth factor would

dramatically alter the results presented here, other than to speed up the response.
Thus the addition of neither BMP nor neurotrophins more accurately
demonstrates the apoptotic potential of NRAGE. That being said, there is the
possibility that the two cascades are inducing apoptosis through separate
pathways. However, as the addition of BMP emphasizes the apoptotic response it
is possible that under these culture conditions BMP treatment overrides the
response to any other serum component. Serum free cultures that include the
addition of individual growth factors may be done in the future to determine if
and how the individual NRAGE protein domains initiate downstream cascades
independently.

The NRAGE MHD is Required for Downstream BMP Activity
Although it has been well established that BMPs can evoke an apoptotic
response, the role of NRAGE in this process has only recently been identified.
BMP ligands and receptors have been shown to co-localize to areas of
neuroepithelial apoptosis

23,25,57

. Studies have also shown in vitro that BMP

signaling induces apoptosis in chick rhombomeres and neural explant cultures.
Noggin, the BMP antagonist inhibits these responses and the over-expression of
BMP receptors can have an effect on cell survival. However, until NRAGE was
categorized as a downstream effector of BNIP-mediated apoptosis, the Msx family
of proteins has been the leading suspects in apoptosis. The Msx family encode
homedomain genes well characterized as transcription factors involved in tooth,
bone and skull formation. The Msx subfamily is extremely well conserved and

the three genes (Msxl, 2, 3) have 98% homology within the homeodomain
region.

In spite of this similarity, they show distinct functions in neural

development, but can still compensate for one another in times of genetic crisis.
Msx genes have been shown to be involved in BMP-induced apoptosis as overexpression of Msx2 in aggregated P19 cells in suspension results in marked
apoptosis

75

. BMP promotes a similar level of apoptosis, however the two

treatments do not show additive effects, signifying that Msx2 and BMP work
through the same mechanism rather than parallel pathways

75.

NRAGE was identified as an interactor with Msx2 in a yeast two-hybrid
screen, thus implicating NRAGE in the Msx2 apoptotic pathway. Although no
studies have determined that NRAGE interacts with Msx2 in neural apoptosis, it
may be an unlikely event as the over-expression of NRAGE induces massive
apoptosis in P19 cells within 48 hours, regardless of the presence or absence of
BMP. BMP accelerates apoptosis in NRAGE over-expressing P19 cells

22,

but

the effects of NRAGE-induced apoptosis is more rapid and context independent
with respect to Msx2. The evidence that NRAGE and Msx2 interact is not in
dispute, however it seems unlikely these two proteins work through a similar
pathway to induce programmed cell death in neural development, especially as
the region of NRAGE that Msx2 binds is not required for apoptosis (i.e. the
WQXPXX repeat region). NRAGE-dependent apoptosis outside of the nervous
system has not been well studied thus it is possible that the two proteins cooperate
in a separate system (such as bonellimb development) to bring about a mutual
response.

To date, NRAGE best fits as a member of the non-canonical BMP
signaling pathway.

NRAGE has been shown to co-immunoprecipitate with

XIAP, TAKl and TAB1 however none of these interactions have been localized
on the NRAGE protein. XIAP has been shown to interact with both BMPRla and
NRAGE through its RING-finger domain. Moreover, TAB1 can interact with
XIAP via its BIR domain and TAKl can induce p38 phosphorylation in the
presence of BMP stimulation. Western blotting shows that the first half of the
MHD is required for p38 activation and this is likely a result of the loss of
NRAGE association with XIAP. However, the region of NRAGE required to
interact with XIAP has not yet been defined, although we may be able to
hypothesize that the C-terminal portion of NRAGE is where XIAP binds, based
on the apoptosis studies described above. Future studies are being designed to
address these issues.

The MHD of NRAGE is Likelv Responsible for its Function Within the
Neurotrophic Theory
NRAGE was first described as an interactor with p75NTRand as such may
play an important role in the neurotrophic theory. Importantly, NRAGE was
found not to bind with the death domain region of p75NTR(the region to which
NADE associates and confers its apoptotic potential)
juxtamembrane region

13

but rather the

. The neurotrophic theory is based on the premise that

neurons which do not receive enough signal in the form of neurotrophins die due
to the lack of survival cues. Although many interactors of p75NTRhave been

identified, there has been a lack of clarity as to the mechanism which p75NTRcan
confer the apoptotic signal.

It has been described that p75NTRcan induce

apoptosis both with and without ligand activation. This is likely cell context
dependent as other studies have showed that p75NTRcan induce apoptosis under
the direction of NGF in cell types such as differentiated rat oligodendrocytes,
Schwann cells, hepatic stellate cells, MAH cells, and many others (reviewed in
54

). However, in vivo data show that apoptosis is reduced when mouse embryos

are exposed to antibodies to NGF or the extracellular domain of p75NTR.There is
also a hypomorphic knockout of the third exon of p75NTRwhich also shows
reduced apoptosis 4s. Furthermore, transgenic over-expression of the intracellular
domain of p75NTRshow decreased cell number in the cortical, sympathetic and
sensory neurons

4"

Studies have also shown that co-expression of p75NTRwith

Trk receptors can augment the affinity of neurotrophins to their respective
receptors. Recently, a ligand for p75NTRhas been described and is ironically, the
uncleaved form of NGF. Pro-NGF appears to be a high affinity ligand for p75NTR,
can not bind with TrkA and can induce p75NTRmediated apoptosis in sympathetic
neurons, oligodendrocytes and vascular smooth muscle cell lines 82,83. Sortollin is
a co-receptor necessary for Pro-NGF to signal upon p75NTR.Overexpression of
Sortollin in cells that do not normally express it renders these cells susceptible to
the pro-apoptotic effects of pro-NGF on the p75NTRreceptor

It is possible, that

in a severe shortage of neurotrophins (to act upon the heterodimeric receptor
complexes), or in cells that do not display the Trk receptors, that p75NTRcan

receive the NGF signal on its own or through pro-NGF stimulation with Sortollin,
either of which evoke the apoptotic response.
NRAGE has not been shown to interact with any of the Trk receptors, nor
Sortollin and over-expression of NRAGE can disrupt the binding of p75NTRto the
Trk receptors. This competitive mechanism of p75NTRbetween Trk and NRAGE
may be responsible for the apoptosis seen in the developing brain. As it has now
been shown that the MHD is required for apoptosis in the developing brain, it
seems likely that this region is responsible for interaction to the juxtamembrane
region of p75NTR,although this has not been confirmed biochemically.
Furthermore, studies are needed to address the role of Sortollin in the pro-NGF
initiated apoptosis response and the role NRAGE has in this mechanism. It is
conceivable that NRAGE may function with p75NTRboth in the presence and
absence of Sortollin to confer apoptosis, and the role of Sortollin in this system
may be to evoke a temporal- or spatial-sensitive response. However, Sortollin
and NRAGE may have little to do with each other and instead the presence of
Sortollin at the p75NTRmay somehow inhibit the p 7 5 N T R interaction.
- ~ ~ ~ ~ ~

NRAGE's Possible Activity as an Axon Guidance Molecule
UNC5H1 is a membrane-associated protein involved in axon guidance and
apoptosis in the brain (reviewed in

"1.

UNC5Hl is the closest related family

member to p75NTR and it has been shown that the PEST and Zu-5 regions of
UNC5Hl are important to interact with the MHD and downstream parts of
NRAGE.

Both p75NTRand UNCSHI have been shown to be important in

neuronal apoptosis and both have a PEST sequence. Although this region is
primarily associated in the rapid turnover of proteins through degradation
machinery, it is interesting to note that these regions in UNC5Hl are
juxtamembrane, the same site where NRAGE interacts with p75NTR.Thus it is
tempting to speculate that these two membrane receptors can mediate apoptosis
through similar mechanisms and interactions with NRAGE. It is interesting to
note that over-expression of UNC5Hl induced substantial apoptosis in native
PC12 cells but not differentiated cells and the over-expression of NRAGE in
differentiated PC 12 cells induced the cells to retract their processes.
Neurotrophins, the ligands of p75NTRand the Trks, are also involved in process
outgrowth. Neurotrophins induce process outgrowth of neural cells as method of
innervating the target tissue from which the trophin is produced. Processes are
essential to this process, perhaps low levels of neurotrophic stimulation encourage
the cell to send out processes but there is an insufficient level of survival stimulus
at the target to sustain all responding cells. Thus the insufficiency of neurotrophin
ends in neurotrophin-mediated apoptosis. It is known that NRAGE is present in
the cell that produces processes and is available to receive the stimulus to
apoptose. It is tempting to speculate that NRAGE is involved (or at least present)
in the search for the neurotrophin-secreting target and that the lack of survival
factor upon reaching the target triggers NRAGE-mediated apoptosis. The exact
stimulus response mechanism is not clear, but future studies may be designed to
investigate the role of NRAGE in this mechanism.

NRAGE's Involvement in Cancer
NRAGE is a member of the MAGE family of genes which were originally
identified as tumor antigens, however, the antigenic function has only been
attributed to type I MAGE clusters A, B, and C.

The MAGE protein is

cytoplasmically processed and the MAGE domain is presented in association with
the antigens of the major histocompatability complex in a variety of tumor cells
including melanoma, breast and prostate

84.

This presentation results in cytotoxic

T cell response and subsequent tumor rejection. Although only expressed in a
certain number of patients, this mechanism has been harnessed for therapeutic
purposes, because when MAGE was experimentally over-expressed in cancer
cells, there was regression when tumor-bearing mice were immunized with
hMAGE-A3
(previous

8"x8

. In a clinical study, HLA-A1 patients who expressed MAGE-3

nomenclature)

on

their

tumors were

administered

MAGE-3

immunization, one quarter of these patients showed a regression of the metastases
however there was no cytotoxic T cell response detected

84.

Currently, there are

more than 6 clinical trials testing the efficacy of various MAGE gene treatments
primarily in multiple melanoma and using MAGE-A genes 89.

BRCA2
Germline mutations in BRCA2 are responsible for predisposing women to
breast and ovarian cancers, and rarely, sporadic mutations are found in breast
tumors.

BRCA2 also has many cellular responsibilities in normal biology

including the stabilization of stalled DNA replication forks, cytokinesis,

gametogenesis, transcription regulation, suppression of cell proliferation and
centrosome duplication (reviewed in 90). BRCA2 has also been shown to inhibit
the proliferation of the pancreatic cancer line Capan-1

90.

Using the conserved

region of the gene, it was found that BRCA2 can associate with the 116 Cterminal amino acid residues of NRAGE with high affinity (figure 4), and
BRCA2 can increase the half life of NRAGE protein six-fold in the presence of
cyclohexamide 90. As many others have implicated NRAGE in the cell cycle,
studies were conducted to determine the role of the BRCA2:NRAGE interaction.
It was seen that both NRAGE and BRCA2 decrease the number of cells that
incorporate BrdU, at a similar rate to p53, and this is an additive effect when both
are transfected in combination

90.

The effects of over-expression of NRAGE and

BRCA2 are similar in a mammary tumor cell line void of p53, suggesting that
repression of the cell cycle is through a pathway independent of p53. However,
growth retardation by BRCA2 is dependent on NRAGE as loss of NRAGE
through RNA inhibition (RNAi) restores the growth potential

90.

The majority of

breast tumor cell lines show low levels of NRAGE expression. However all the
untransformed mammary epithelial cell lines and four of the more than twenty
tumor lines show significant NRAGE expression. This signifies that NRAGE
expression may be important in maintaining an normal state 90.

Recently there have been two studies which show an association of
NRAGE and cancer. However, the revelation that NRAGE is associated with
cancer is not surprising since apoptotic cascades have long been associated with

the disease as they are likely targets for mutations. NRAGE and BRCA2 together
induce growth inhibition and some rare breast cancer cell lines (4 of more than 20
studied) show a lack of NRAGE protein. Furthermore, in a separate study, it was
seen in rare subset of well differentiated yet highly invasive breast tumors, there
are disproportionately high levels of BMPRlb and XIAP

9'.

Although not

directly studied or mentioned, it may be there is a loss of NRAGE activity
associated with these two proteins, which can cooperatively associate to induce
apoptosis. Although there is little data to back this up, normal BRCA2 may be
able to extend the half life of NRAGE and thus repress the malignant growth of
cells. Upon loss of or mutation of BRCA2, there is subsequent rapid degredation
and loss of NRAGE protein which in turn leads to a decrease in apoptosis. This
and over-expression of BMPRlb and XIAP could both contribute to breast cancer
through similar or different mechanisms. There is much to study to confirm this,
but if true, NRAGE could be involved in breast cancer progression.

Chapter 5

LIMITATIONS AND FUTURE STUDIES

Limitations of the Presented Studv
This study utilized a cloning strategy that drastically reduced the NRAGE
protein in order to isolate the recognized regions. In light of the Necdin structurefunction study, in which the authors deleted only the region of interest without
interfering with the upstream or downstream regions of the protein, it would be
appropriate to deconstruct NRAGE in a similar manner to compare these sibling
proteins. Furthermore, a less drastic manipulation of the protein would also more
accurately demonstrate the true function of the region by minimizing the
conformational changes and the ancillary functions of the upstream regions.
However, by employing the cloning strategy'outlined in this study, we may have
discovered a function in the MHD2 region, as we have shown that the loss of the
MHD2 changes the subcellular distribution only when the MHD is intact.
Technical difficulties are abundant when studying a protein involved in
apoptosis, as it is difficult to maintain a population of expressing cells. Apoptosis
as measured by flow cytometry was evaluated at 48 hours, however data not
presented here demonstrated that at 24 hours we did show a similar pattern of
degree of cellular death. Thus, Western blot and sub-cellular expression analysis

was performed at 24 hours as it was found that the protein was more abundantly
expressed at this time point. However, it was still problematic to transfect the
constructs, especially the longest ones and detect these proteins through western
blot analysis. The longest fragment is ten times larger than the smallest fragment,
thus transfection with equal weights revealed that the shorter fragments had
consistently greater expression due to the number of plasmids integrated into the
cell.

However, pre-experimentation transfections revealed that altering the

amount of plasmid transfected did not drastically alter the degree of expression in
the cells. This is likely due in part to the optimization of the Lipofectamine
transfection protocol, which 'maxes out' the plasmid:liposome ratio in the media.
Altered sub-cellular localization was shown with the NRAGE mutant
constructs through epifluorescence microscopy however, it can not be definitely
concluded that there was no localization to the membrane. To validate these
conclusions, confocal microscopy using P19 cells expressing the NRAGE
constructs is required.

Furthermore co-staining with markers specific for the

apoptosome (APAF1 or caspase 9) or the golgilendoplasmic reticulum would
further elucidate where in the cell these mutant proteins aggregate.

Future Studies
In order to fully characterize the structure-function analysis of NRAGE,
the proliferation and differentiation aspects of NRAGE function need to be
investigated. Previous reports have shown that NRAGE expression can influence
the cell cycle through its actions on p53 activityz2. Overexpression of NRAGE

attenuates BrdU incorporation which signifies an exit from the cell cycle.
Therefore, BrdU incorporation assays, utilizing flow cytometry to read the
percentage of GFP+ cells that incorporate BrdU, would identify changes in the
cell cycle dynamics of cells expressing the NRAGE mutant constructs. It is
expected that an intact MHD would abbreviate the cell cycle and induce a more
rapid exit from the cell cycle, while the loss of the MHD would when the latter
constructs are overexpressed would not alter the cell cycle kinetics.
It has also been demonstrated that the loss of NRAGE can alter the
differentiation potential of P19 cells, as there is a reduction in the production of
neurons at a result of the cell failing to cease the progenitor genetic program. A
thorough analysis of the NRAGE mutants described here, as well as the GFP
control, transfected into PI9 cells then taken through the retinoic acid-mediated
differentiation program would be warranted. At the termination of the program,
cells would be stained for MAP2alb (a neural marker), GFAP (a glial marker) and
Mash1 (a neural stem cell marker) to determine the percentages of the cells in the
various developmental stages. As Kendall et al. ", showed that with a loss of
NRAGE there is a gain of progenitors at the expense of neural populations (at 8
days of differentiation), it would be expected that the loss of the MHD would
show similar results (i.e. F7, F8, and F9R2) as there would be no functional
NRAGE signal. However, the overexpression of the constructs with the MHD
intact would induce a rapid cell cycle exit which would allow the cells to
terminally differentiate more quickly which would be seen by an increase in glialpositive cells.

We have demonstrated that the loss of portions of the NRAGE protein can
alter the co-localization of the remaining protein to discrete regions of the cell
upon over-expression. These results are consistent with the structure-function
analysis of Necdin in which mutants that do not encode for the MHD or the N
terminus are distributed uniformly in the cytoplasm. Although we have seen that
some of the NRAGE mutants built may reside by or in the nucleus, in aggresomes
or apoptosomes, confocal imaging with other markers is required to confirm
nuclear localization or localization within aggregated structures. To elucidate
whether the apoptosome is the where the construct concentrates, tagged molecules
of the apoptosome such as a pro-caspase 9 or APAFl construct will help define
whether this structure is the apoptosome. However, NRAGE may also co-localize
with other known interactors, such as TAKl and TAB1, or p38 in the noncanonical BMP pathway, MsxIDlx, or Necdin.

Necdin deletion mutants can

subcellularly localize, thus these two proteins may work in a similar mechanism
to elicit downstream responses and their mutants behave in an analogous fashion.
Indeed, future studies employing both NRAGE and Necdin may shed significant
light on the role of the MHD in functions other than MHC-mediated cytotoxic T
cell response.
XIAP is a known mediator of the non-canonical BMP signaling and also
interacts with NRAGE. However, it not known with which region of NRAGE
XIAP can interact, thus co-immunopreciptation of the NRAGE constructs with
XIAP (as a XIAP-dsRed monomer construct or endogenously) will help to
determine where XIAP interacts with NRAGE. Furthermore, it is still unknown

where XIAP and NRAGE meet within the cell to confer the apoptotic signaling.
In light of the interesting result of the NRAGE cellular localizations, confocal
imagery of the two proteins (as GFP and dsRed constructs, or YFPICFP
constructs which are currently being prepared) will help determine where in the
cell the two proteins interact. These interaction studies may also shed light onto
the interesting results seen in this study on the MHD. Several lines of evidence
justify the hypothesis that XL4P interacts with the N-terminal half of the MHD.
Caspase 3 and p38 activation occur in the absence of the N-terminal MHD
whereas apoptosis is not apparent when the N-terminus of the MHD is intact. If
XIAP does interact here, it stands to reason that XIAP inhibits NRAGE-mediated
apoptosis even in the presence of caspase 3 activation. However, when binding of
XIAP is lost, then the C-terminal portion of the MHD can signal apoptosis, as
seen in the Annexin V data.
NRAGE

was

first

identified as molecule

interacting with

the

juxtamemembrane region of p75NTRhowever, little has been found as to the
downstream activities of NRAGE after p75NTRinteraction. Future studies must
address this issue. Published yeast-two-hybrid screens have only uncovered the
E3 ubiquitinating protein Prajal as interacting with NRAGE. A second screen,
focusing on the MHD may help elucidate downstream interactors of NRAGE
under the control of p75NTR. Furthermore, 2-dimensional gel analysis of
neuroblasts and neurotrophin-stimulated neuroblasts may help elucidate changes
in protein expression that could be attributed to apoptosis. On the other hand, the
discovery of Sortollin and pro-NGF as the ligand and co-receptor of p75NTRmay

also be of interest to future NRAGE-focused studies. As mentioned above, these
molecules may play a role in the upstream mediated response of p75NTRand
ultimately the fate of the cell itself.
Surprisingly, none of the mutant NRAGE molecules built appeared to
show a sub-cellular localization to the membrane compartments. This is
surprising as NRAGE is known to interact with at three membrane-bound
receptors (p75NTR, BMPR, UNC5Hl). Future studies using construct-bearing
cells treated with either BMP or neurotrophins may show that certain constructs
can move to the membrane-associated receptor upon appropriate stimulation. The
NRAGE mutants were inserted into the pEGFP construct so as to detect its
expression as all commercially available NRAGE antibodies have epitopes to the
N-terminus.

Antibodies generated to recognize the extreme C-terminus or the

MHC of NRAGE would be useful to confirm these findings.
As stated above, these studies were all performed in the presence of
serum, however, the addition of ligands may influence the translocation of the
molecule in the cell. These studies will also shed light onto the requirements of
the receptor-mediated apoptotic signaling cascade on NRAGE. This would clarify
NRAGE is itself responsible for the downstream be through its own interaction
with NRAGE or the necessary downstream cascades that NRAGE interacts with
to confer its apoptotic potential. These studies will help determine whether the
deletion of a specific region prevents apoptosis at the membrane level or
downstream of NRAGE.
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